Basic Information
Basic information for SNHG14-235-43aa
Peptide Name SNHG14-235-43aa
Genome Position chr15:25108036-25108038,25108998-25109099,25109198-25109221[+]
Species Human
Peptide Sequence MVDFTVNLNRSWKKDFKHSPVLWNKYTFFWTYTLSVPCDTRVA
Peptide Length 43
Unique No (SNHG14-227-43aa-2,SNHG14-238-43aa,SNHG14-257-43aa,SNHG14-281-43aa,SNHG14-287-43aa,SNHG14-301-43aa,SNHG14-304-43aa-2,SNHG14-311-43aa-1,SNHG14-314-43aa,SNHG14-316-43aa,SNHG14-342-43aa-1)
Grand Average of Hydropathicity -0.3116
Relative Molecular Mass 5999.83
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000655153;SNHG14-235
Transcript Length 7914
Coding Ability 0.4272
DNA Sequence Corresponding to Peptide ATGGTGGACTTTACGGTTAACCTGAACAGGTCTTGGAAAAAGGACTTTAAACATTCTCCTGTTCTGTGGAATAAGTATACTTTTTTCTGGACATACACCTTGTCAGTTCCATGTGATACTAGAGTTGCA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :